Kathleen Meriwether is the Americas Leader of the Health Sciences team of Ernst & Young’s Fraud Investigation & Dispute Services practice. Kathleen specializes in assisting health sciences companies with global risk and compliance assessments and regulatory compliance analyses. Kathleen works closely with management teams, compliance officers and counsel to identify compliance and enforcement risks, determine potential vulnerabilities and recommend solutions from business and operational perspectives. Kathleen also assists counsel, both outside and in-house, with fraud investigations (health care fraud and abuse, off label marketing, FCPA and other bribery and corruption), compliance inquiries and in strategizing responses to governmental subpoenas and other inquiries. She has also worked on multiple projects assisting in-house counsel on management of significant litigation matters, from the cost management as well as investigative perspectives.
Prior to her tenure with EY, Kathleen was an Assistant United States Attorney in the U.S. Attorney’s Office for the Eastern District of Pennsylvania, focusing on health care fraud in the life sciences industry.
Before becoming an AUSA, Kathleen spent over 16 years with Bristol-Myers Squibb Company in a number of legal, regulatory affairs and compliance positions, including as division counsel for the Oncology and Immunology franchise. Kathleen’s industry experience includes such diverse areas as management of multi-district product liability and antitrust litigation, commercial litigation, labeling and promotional compliance, research and development, sales and marketing practices, including off-label marketing and fraud and abuse, government pricing and relationships with third parties, from contract research and sales organizations to licensors/ees and marketing partners. Kathleen began her legal career as an associate with a national law firm based in Philadelphia.